chronic lymphocytic leukaemia

Roche/AbbVie drug could further improve prognosis in CLL

https://pharmaphorum.com/news/venetoclax-improve-prognosis-cll-doctor/

Roche/AbbVie combination could raise standards in CLL

https://pharmaphorum.com/news/rocheabbvie-combination-better-chemo-cll/

Leukaemia patients to get access to AbbVie’s Venclyxto via Cancer Drugs Fund

https://pharmaphorum.com/news/cll-patients-england-get-access-abbvies-venclyxto-nice-u-turn/

Spectacular early results for Novartis’ CAR-T combined with Imbruvica

https://pharmaphorum.com/news/spectacular-early-results-novartis-car-t-combined-imbruvica/

NICE rejects AbbVie/Roche CLL drug Venclyxto

https://pharmaphorum.com/news/nice-rejects-abbvie-cll-drug/

AbbVie’s Venclyxto approved in Europe in CLL

https://pharmaphorum.com/news/abbvies-venclyxto-approved-europe-cll/

AbbVie’s CLL drug recommended in Europe

https://pharmaphorum.com/news/eu-regulators-back-abbvie-drug-cll/

Novartis’ Arzerra gains CLL approval

https://pharmaphorum.com/news/novartis-arzerra-gets-new-us-cll-use/

NICE rejects Janssen’s CLL drug

https://pharmaphorum.com/news/nice-rejects-janssens-cll-drug/

Close in 10 seconds

Pharmaphorum.com

Search